NCT00065572暂停2 期
Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 暂停
- 发起方
- AstraZeneca
- 试验地点
- 16
研究概览
简要总结
The purpose of this study is to assess the biological activity of ZD6126 in subjects with newly diagnosed metastatic renal cell carcinoma (stage IV).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Newly diagnosed metastatic renal cell carcinoma
- •Suitable for nephrectomy
排除标准
- •Prior chemotherapy, biological therapy or radiation therapy for renal cell carcinoma or within the last 3 years for any other cancer
- •Significant cardiac event within 3 months of entry
- •Any history of coronary angioplasty or history of myocardial infarction
研究者
研究点 (16)
Loading locations...
相似试验
已完成
1 期
Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT01082120AstraZeneca28
撤回
1 期
A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of WarfarinPharmacokineticsPharmacodynamicsNCT01214122AstraZeneca
已完成
1 期
Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male VolunteersHealthyNCT01588626AstraZeneca12
已完成
不适用
Evaluating the biological effects of pre-operative intravenous administration of JX-594 (thymidine kinase-deactivated Vaccinia virus plus GM-CSF) prior to planned surgical resection of locally advanced/poor prognosis or metastatic cancers.CancerISRCTN13913966niversity of Leeds40
已完成
1 期
Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy VolunteersRenal ImpairmentNCT00733265AstraZeneca24